Evidence suggests reactivations of the varicella-zoster virus may accelerate aging and raise dementia risk. Now scientists want to know if vaccines and antivirals could help protect the brain.

Spread the loveThe Shingrix vaccine, primarily known for its role in preventing shingles, has recently been linked to a surprising benefit: the suppression of inflammaging. This phenomenon, ...

A health worker prepares to administer a vaccine in Los Angeles, California in January 2022 - Copyright AFP/File Frederic J. BROWN A health worker prepares to ...

Herpes zoster, commonly known as shingles, is the result of reactivation of the latent varicella-zoster virus (VZV), which initially causes varicella (chickenpox). Following primary infection, VZV ...

Researchers report an alarming increase in varicella zoster virus (VZV) infections in adults calling for vaccination and public health measures The study was led by Professor Tetsushi Yoshikawa, along ...

One of the largest studies ever conducted on the link between the shingles vaccine and brain health offers insight into how the disease increases dementia risk. People who experienced multiple ...

Scientists have discovered a new evasion strategy used by the varicella zoster virus, which causes chickenpox and shingles, that may allow it to affect tissues far from the original site of infection.

The classic laboratory methods for the detection and differentiation of HSV-1/2 and VZV, including Tzanck smear testing, viral culture, DFA testing and serologic testing, have been well documented in ...

Announcing a new article publication for Zoonoses journal. Because varicella zoster virus (VZV) infections are continually increasing, vaccine efficacy must be enhanced. To date, the inefficient in ...